Skip to content

Treatment of Lower Back Facet Pain with Autologous Bone Marrow Aspirate

Autologous Bone Marrow Aspirate Injection for the Treatment of Chronic Lumbar Facet Joint Pain: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-64qvcwp
Enrollment
Unknown
Registered
2025-12-08
Start date
2025-10-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facet joint pain

Interventions

This is a randomized controlled two-arm double-blind clinical trial composed of forty participants allocated into two groups of twenty participants each through a computer-generated random sequence wi
blinding will be applied so that both the participant and the evaluator responsible for outcome assessment remain unaware of group allocation, while only the physician performing the infiltration proc

Sponsors

HOME - Hospital Ortopédico e Medicina Especializada - LTDA
Lead Sponsor
HOME - Hospital Ortopédico e Medicina Especializada - LTDA
Collaborator

Eligibility

Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: Participants aged eighteen years or older; chronic low back pain refractory to conservative treatment, including failure to respond to simple analgesics, nonsteroidal anti-inflammatory drugs, and adjunct therapies such as physical therapy and acupuncture; positive diagnostic test for facet syndrome, including worsening of low back pain during trunk extension after diagnostic facet block with lidocaine and pain relief equal to or greater than fifty percent on the visual analog scale within four hours after the block; confirmed diagnosis of facet syndrome by magnetic resonance imaging demonstrating facet arthritis or arthrosis

Exclusion criteria

Exclusion criteria: Presence of preexisting neurological deficit; rheumatologic disease; coagulopathy; pregnancy; allergy to local anesthetics; contraindication or adverse effects related to corticosteroid use; previous lumbar spine surgery; lumbar tumor; spondylolisthesis; low back pain without an identifiable cause

Design outcomes

Primary

MeasureTime frame
A reduction in the intensity of low back pain assessed by the Visual Analog Scale is expected, as well as an improvement in functionality assessed by the Oswestry Disability Index questionnaire, with a clinically significant difference between baseline and the follow-up assessments at one, seven, thirty, ninety, and one hundred eighty days after the intervention

Secondary

MeasureTime frame
A low frequency of adverse events and complications is expected, assessed through identification, classification, and clinical monitoring of events during the baseline period and at one, seven, thirty, ninety, and one hundred eighty days after the procedure in both groups. Greater clinical satisfaction is expected in the experimental group compared with the control group according to the MacNab criteria, assessed by the clinical response classification at the same follow-up time points

Countries

Brazil

Contacts

Public ContactDiovanni Pereira

HOME - Hospital Ortopédico e Medicina Especializada - LTDA

diovanniunb@gmail.com+55(61)99870-1010

Outcome results

None listed

Source: REBEC (via WHO ICTRP)